135 related articles for article (PubMed ID: 32028300)
1. Scleromyxedema and Hyperphosphatemia: Causal Relationship or Coincidence?
Mousavi S; Masoumi M; Shakiba S
J Clin Rheumatol; 2021 Aug; 27(5):e160-e161. PubMed ID: 32028300
[No Abstract] [Full Text] [Related]
2. [Scleromyxedema with neurological symptoms: successful treatment with immunoglobulins].
Manríquez J; Berroeta-Mauriziano D; Andino-Navarrete R; Vera-Kellet C
Med Clin (Barc); 2015 Jan; 144(1):47-8. PubMed ID: 24656121
[No Abstract] [Full Text] [Related]
3. Scleromyxedema.
Chatterjee S; Fernandez AP
N Engl J Med; 2023 Nov; 389(21):1992. PubMed ID: 37991858
[No Abstract] [Full Text] [Related]
4. Specific lymph node involvement in scleromyxedema: a new diagnostic entity for hypermetabolic lymphadenopathy.
Delyon J; Bézier M; Rybojad M; Brière J; Validire P; Bagot M; Janin A; Battistella M
Virchows Arch; 2013 Jun; 462(6):679-83. PubMed ID: 23681113
[TBL] [Abstract][Full Text] [Related]
5. Acute Encephalitic Syndrome Induced by Scleromyxedema.
Magira EE; Malouchou A; Karathanasi V; Mavropoulou N; Siempos II; Vourlakou C; Sykaras A; Anastasiadis G
Am J Med Sci; 2020 Aug; 360(2):192-195. PubMed ID: 32540147
[TBL] [Abstract][Full Text] [Related]
6. [Good response of scleromyxedema and dermato-neuro syndrome to treatment with intravenous immunoglobulins].
Bielsa I; Benvenutti F; Guinovart RM; Ferrándiz C
Actas Dermosifiliogr; 2012 May; 103(4):317-20. PubMed ID: 21917233
[TBL] [Abstract][Full Text] [Related]
7. Dermato-neuro syndrome in a patient treated with autologous stem cell transplant for scleromyxedema.
Shams SR; Goldstein DA; Kaufman JL; MacKelfresh J; Flowers CR; Langston AA
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):e213-5. PubMed ID: 25065780
[No Abstract] [Full Text] [Related]
8. [Marked improvement in scleromyxedema with high-dose intravenous immunoglobulin].
Topf S; Simon M; Schell H; Lüftl M
Hautarzt; 2007 Jun; 58(6):525-8. PubMed ID: 17165069
[TBL] [Abstract][Full Text] [Related]
9. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
Manousaridis I; Loeser C; Goerdt S; Hassel JC
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
[TBL] [Abstract][Full Text] [Related]
10. Scleromyxedema.
Bogner RR; Wetter DA; Dingli D
Intern Med; 2014; 53(21):2561-2. PubMed ID: 25366027
[No Abstract] [Full Text] [Related]
11. Dermato-neuro syndrome after COVID-19 infection in a patient with scleromyxoedema: Previously successful treatment with intravenous immunoglobulins.
Li Y; Wang H; Wang A; Zhao G
J Dermatol; 2024 Jan; 51(1):140-144. PubMed ID: 37830263
[TBL] [Abstract][Full Text] [Related]
12. Fever, Joint Pain, Seizures, and Rash in a 53-Year-Old Woman.
Weiner J; Marano A; Cardones A; Criscione-Schreiber L
Arthritis Care Res (Hoboken); 2017 Sep; 69(9):1437-1443. PubMed ID: 28376294
[No Abstract] [Full Text] [Related]
13. Scleromyxedema.
Hoffmann JHO; Enk AH
J Dtsch Dermatol Ges; 2020 Dec; 18(12):1449-1467. PubMed ID: 33373143
[TBL] [Abstract][Full Text] [Related]
14. Myopathy and scleromyxedema.
Soulages A; Tang HM; Pham-Ledard A; Négrier-Leibreich ML; Cosnard A; Duval F; Solé G; Carla L; Le Masson G; Mathis S
J Neurol; 2019 Aug; 266(8):2051-2059. PubMed ID: 31115676
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of scleromyxoedema in an Afro-Caribbean man.
Ufodiama CE; Tynes G; Unwala R
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30665930
[No Abstract] [Full Text] [Related]
16. [Monoclonal immunoglobulin (M-Ig) and skin diseases from the group of mucinoses--scleredema adultorum Buschke and scleromyxedema. Description of four cases and an overview of therapies].
Adam Z; Szturz P; Krejčí M; Vašků V; Pour L; Michalková E; Ševčíková S; Čermáková Z; Veselý K; Vaníček J; Pourová E; Král Z; Mayer J
Vnitr Lek; 2015 Dec; 61(12):1072-87. PubMed ID: 26806503
[TBL] [Abstract][Full Text] [Related]
17. Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema.
Brunet-Possenti F; Hermine O; Marinho E; Crickx B; Descamps V
J Am Acad Dermatol; 2013 Aug; 69(2):319-20. PubMed ID: 23866873
[No Abstract] [Full Text] [Related]
18. An unusual presentation of scleromyxedema as inflammatory myopathy.
Vysakha KV; Poyuran R; Nair SS; Nair M
Acta Myol; 2019 Mar; 38(1):13-16. PubMed ID: 31309176
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up in a patient with the dermato-neuro syndrome treated with high-dose melphalan, thalidomide, and intravenous immunoglobulins for more than 7 years.
Devos T; Thiessen S; Cuyle PJ; Meersseman W; Delforge M
Ann Hematol; 2014 Nov; 93(11):1927-8. PubMed ID: 24676971
[No Abstract] [Full Text] [Related]
20. Scleromyxedema.
Hummers LK
Curr Opin Rheumatol; 2014 Nov; 26(6):658-62. PubMed ID: 25215418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
